This HTML5 document contains 244 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1017/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37419563
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в березні 2009 artigo científico wetenschappelijk artikel مقالة علمية نشرت في 23 مارس 2009 articolo scientifico videnskabelig artikel wissenschaftlicher Artikel artículu científicu espublizáu en 2009 scientific article published on 23 March 2009 vedecký článok vědecký článek bilimsel makale article scientifique article científic научни чланак vetenskaplig artikel
p:P577
wds:Q37419563-19DEF296-4609-4221-81BF-9573D4DDB7E1
wdt:P577
2009-03-23T00:00:00Z
p:P2860
wds:Q37419563-74950B67-9048-49D7-8129-02FE81366FB5 wds:Q37419563-7CB80A3F-CD57-430E-9DC3-D91BFF82837F wds:Q37419563-8321D42F-4618-4B52-8D04-EFB75757D474 wds:Q37419563-851F2542-20F1-4451-ABC9-A617716DD129 wds:Q37419563-86201BEF-56CF-4EFD-BEC0-28A317ACD5B8 wds:Q37419563-896950FB-292C-484D-950A-B09C43186766 wds:Q37419563-8A9539E9-3C9F-4495-A657-EFCCBE0E49A7 wds:Q37419563-901846C8-C41B-4054-984D-D1FCBBCE1BDF wds:Q37419563-5FE1466A-B446-4455-855E-5F2B21D9CE49 wds:Q37419563-605D6EF3-B537-4DCA-A7E7-2E9A8D70BC9F wds:Q37419563-627A1A8B-262A-443D-BE9B-648BCE8069F0 wds:Q37419563-67EF4CAD-CC8B-49E8-9338-F4C783FBF5ED wds:Q37419563-69336A2B-D0DF-4EE5-9063-78A931852313 wds:Q37419563-6C8A3183-AC2A-49AE-AB21-FB4095EE4A56 wds:Q37419563-6CEC32DE-2AFD-4F46-9857-40E1FA3E90E3 wds:Q37419563-6E58D5BF-AAF6-443A-834B-A3C5DBEC0041 wds:Q37419563-A52B88C4-36B8-466F-BBBD-FDB060129960 wds:Q37419563-ACA8EFAF-BC27-4B42-A3A7-B2B425CE27A9 wds:Q37419563-AF60FB3C-51FC-4BA1-B809-034C2F862897 wds:Q37419563-B3F729C5-F41B-4FD1-B05D-C1300ACC2C27 wds:Q37419563-B59A296A-5985-460A-988D-C7E709B4B564 wds:Q37419563-B75F2895-DF9B-449E-ADA2-8F5E768B3745 wds:Q37419563-BD00A799-2617-4DB9-B435-877BB9C14451 wds:Q37419563-92F808F3-157A-4030-ABBE-CE06AE70C261 wds:Q37419563-94856AF3-D9A6-4CC4-B476-D454A8C41CCD wds:Q37419563-97C9AA8C-1086-41A9-96D4-4E682BA4FF3A wds:Q37419563-995D6288-E663-47FD-99CD-251B373C5857 wds:Q37419563-9B0D6716-796F-4624-8465-6BD37ED5E43D wds:Q37419563-A2958B0C-33CB-4D09-ACA3-5D3D9BA6B888 wds:Q37419563-CB34EDC0-34F6-4CE7-8821-5791963C79E0 wds:Q37419563-CFF5F0C5-2B87-46BF-BE80-1B7BC87E1F2C wds:Q37419563-D2A10826-1D51-47F2-9EEA-D6436EA1D782 wds:Q37419563-D55FC933-3613-4C9F-971C-9EE1EA5045CC wds:Q37419563-D682E3FB-115D-47D8-9919-1093240A3596 wds:Q37419563-E0E64ACA-EF79-487C-B602-21477F235C9D wds:Q37419563-E0FBC869-6162-4046-961D-F173EEF66400 wds:Q37419563-E4369951-508A-4C83-B2F3-A95A7F71CB01 wds:Q37419563-BDD5FFF3-8E6D-4BB9-8E03-D216AE645EA7 wds:Q37419563-C0238CAE-9488-40B6-B302-DCD2AE957262 wds:Q37419563-C1236407-94A4-4ADC-B53C-84A042196438 wds:Q37419563-C4BBAE6F-54D9-4832-9AFA-15C9B13DB409 wds:Q37419563-C4FA8D57-6C6E-48AC-8E85-573BC07285DD wds:Q37419563-C5229FE7-21F5-4C02-AE56-DEEA096BC60B wds:Q37419563-C618F2B2-963C-4FE6-98A5-A10643CA1E91 wds:Q37419563-F4DACBC6-3B71-4126-8B25-56D8E6535577 wds:Q37419563-F87BC55A-F61A-4904-947B-2906273DA3A0 wds:Q37419563-F9510506-FF0C-46AF-B5AE-6B597186F745 wds:Q37419563-FB9A75D8-FD36-4946-A18B-4EE840DA17B3 wds:Q37419563-FDEF6531-DB50-42A6-B84F-DFA497C7160F wds:Q37419563-FFF14979-BD9A-4C1C-B1F3-4DD681D5A638 wds:Q37419563-E52FD8EE-44D4-42BF-9514-70F92A9A83AE wds:Q37419563-E571AE8E-D538-4136-BD1A-AD01329BE90B wds:Q37419563-E9CF6DA8-865C-4716-ACC1-C457FA68BF4A wds:Q37419563-EEECCC40-A0E2-4859-9381-D53BF9E3A489 wds:Q37419563-F1FF1C3D-5CD2-40F7-B085-6A38D001CD6D wds:Q37419563-F230ABB4-B407-4631-93FA-63D5CC87C367 wds:Q37419563-F30DED1E-EDAA-4692-A20D-6C574C770F53 wds:Q37419563-08D27EA1-6908-4EC5-9F49-52A9097A3946 wds:Q37419563-09BC26F1-1549-40EB-A7AF-D2971F6D8FEF wds:Q37419563-0D1F5929-EFE7-42CC-AE68-4DCAD3F8550E wds:Q37419563-0FF6EB5B-8704-448E-B6EF-74D14537D359 wds:Q37419563-105CD4BC-7F4D-407E-A34A-62C0923AFD6A wds:Q37419563-11F6922B-4F31-403D-9450-8A62AAB31472 wds:Q37419563-13E33DDA-70A0-4483-BA0E-72EF04D820F2 wds:Q37419563-00FD74C6-5DF3-46A3-A248-AD08F363197B wds:Q37419563-01352CE8-5B21-4935-BAF3-5E60BDEAAC65 wds:Q37419563-04A77B79-59C3-44DF-B3ED-EA633AC7EE2B wds:Q37419563-053FDB60-B5FC-414F-B695-574CE1E7B51F wds:Q37419563-0592A4E1-71B2-468E-B7C3-028929255B3A wds:Q37419563-07DA06A7-3844-4D9A-BB87-4DE3DF6FBB1A wds:Q37419563-282024D2-AD6C-4DCD-9729-2983E1001D81 wds:Q37419563-285EB426-7D39-4E35-B545-4B2F1E61CA7A wds:Q37419563-289E8DE4-338A-4411-A757-E43CF46FFF4F wds:Q37419563-2A0C7072-BF31-4D04-97DC-6E8B085A0DFF wds:Q37419563-2EFDFFE1-55D5-40C8-BCCC-E62A10A59DA7 wds:Q37419563-30835223-AD46-48AE-A5BF-AF5AA3B1C39C wds:Q37419563-31228F51-721E-4C36-8908-B44120C54BA6 wds:Q37419563-146C4FC1-2222-451A-84E7-F403348D7F8E wds:Q37419563-1B235FD2-A13F-46F1-ABAF-BDCD88AA21C2 wds:Q37419563-1D0F33E0-E717-41AB-B536-3B5E8D16DF12 wds:Q37419563-1E17148F-CC1A-4C54-9D22-70640B6FFECD wds:Q37419563-1E2C0B72-DCF2-4E28-8B7E-4CED274EDDD2 wds:Q37419563-26BA9AEF-4445-4D23-8D7A-CAAD3A6FB856 wds:Q37419563-279C5CBA-A853-4676-9460-893930472431 wds:Q37419563-4FBA3EA6-8982-4D7D-8C16-A89021A21FBF wds:Q37419563-5113AF08-D665-476C-A468-5B7415160A6E wds:Q37419563-5314053F-D8BE-430B-B39A-DFB0CA0AC0C2 wds:Q37419563-53BBE702-1148-478E-8855-6632D1869209 wds:Q37419563-54331ABF-03E6-4234-8851-5F9B1D324E51 wds:Q37419563-55AB0BAC-85BE-4236-94E5-F332BDB73F3D wds:Q37419563-5DEA03B7-7A16-44E0-84EA-4D71CABACCED wds:Q37419563-35F7635D-3BD9-4D3A-AB5C-25CB1E989476 wds:Q37419563-37ADD66B-4922-4DBC-B021-E245F2D90DB2 wds:Q37419563-3F4DE134-8D42-489E-A390-15A60F6A67C3 wds:Q37419563-41DEB76D-2599-4FF1-9130-D4776060A57B
wdt:P2860
wd:Q45270105 wd:Q35596970 wd:Q36974650 wd:Q45862142 wd:Q42800196 wd:Q40990939 wd:Q81307925 wd:Q55042558 wd:Q35079319 wd:Q35928850 wd:Q39777950 wd:Q41004716 wd:Q24555118 wd:Q38364075 wd:Q34351307 wd:Q41687773 wd:Q40077258 wd:Q40730581 wd:Q40636653 wd:Q44034821 wd:Q44353860 wd:Q40955831 wd:Q74337134 wd:Q44212614 wd:Q33738466 wd:Q44881564 wd:Q40572385 wd:Q58183450 wd:Q40629963 wd:Q71121145 wd:Q45882778 wd:Q36718049 wd:Q46917397 wd:Q36789789 wd:Q38290811 wd:Q36390910 wd:Q38296093 wd:Q44264343 wd:Q44626679 wd:Q50750187 wd:Q37189998 wd:Q57261221 wd:Q44220923 wd:Q42996491 wd:Q28266775 wd:Q38315573 wd:Q35553201 wd:Q46033759 wd:Q45870554 wd:Q42802043 wd:Q36499173 wd:Q34522196 wd:Q40458431 wd:Q38347354 wd:Q79447053 wd:Q36978824 wd:Q33361839 wd:Q45876203 wd:Q38549855 wd:Q40415937 wd:Q38306474 wd:Q47238681 wd:Q51932521 wd:Q46886020 wd:Q40350463 wd:Q39731474 wd:Q28359458 wd:Q33219914 wd:Q45863474 wd:Q80441677 wd:Q38364095 wd:Q73375452 wd:Q33372613 wd:Q33715654 wd:Q83917725 wd:Q42473901 wd:Q33987188 wd:Q36440335 wd:Q35545118 wd:Q33374227 wd:Q40199281 wd:Q40684788 wd:Q28263669 wd:Q54543511 wd:Q34004782 wd:Q35856054 wd:Q79948026 wd:Q36052460 wd:Q46048333 wd:Q44960581 wd:Q38300106 wd:Q41669806 wd:Q72779505 wd:Q37193000 wd:Q45238109
p:P2093
wds:Q37419563-EDADD2CA-9621-4F86-942B-4C31E4A388DF wds:Q37419563-4347B9AF-F52F-4868-A364-CC0040512915
wdt:P2093
Frank Anastasopoulos Paul J White
rdfs:label
Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
skos:prefLabel
Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
schema:name
Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
p:P50
wds:Q37419563-359D96F2-ABAB-4298-B9C9-57019F0A723B wds:Q37419563-939A3503-D95E-43EB-8882-5D90C61A2907
wdt:P50
wd:Q41608617 wd:Q38804793
p:P1476
wds:Q37419563-919E1505-C08C-493C-9022-ECB022277E56
wdt:P1476
Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides
p:P304
wds:Q37419563-5471E019-8C3D-4055-8894-BA0822500591
wdt:P304
e10
p:P31
wds:Q37419563-28e7e819-b764-417c-a287-45cebb500bcf wds:Q37419563-1021669C-8CB8-47AA-8315-043DDAF4C6FC
wdt:P31
wd:Q7318358 wd:Q13442814
p:P698
wds:Q37419563-34E56350-51B6-4AF0-872C-65155D229867
wdtn:P698
n11:19302730
wdt:P698
19302730
p:P1433
wds:Q37419563-C5104DC5-A61E-4722-A28E-F3E76EC0A930
wdt:P1433
wd:Q15755244
p:P478
wds:Q37419563-35FC363E-74F5-4F91-9D18-D46D52B9972E
wdt:P478
11
p:P356
wds:Q37419563-AFA5FBE4-FD46-4BB9-842E-38259183E915
wdtn:P356
n8:S1462399409001021
wdt:P356
10.1017/S1462399409001021